Balyasny Asset Management
ARA

Balyasny Asset Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Balyasny Asset Management’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,387
Closed -$195K – 2188
2018
Q2 		$195K Buy
+12,387
New +$195K ﹤0.01% 1651

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Balyasny Asset Management's ARA Position: Q3 2018 in Review

Balyasny Asset Management sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2018, closing a stake of 12,387 shares — an estimated $195K sold.

Balyasny Asset Management first reported a position in ARA in Q2 2018 and held it in 1 quarter. The position peaked at $195K in Q2 2018. 82 funds tracked by Wall St. Rank hold ARA as of Q3 2018.

  • Balyasny Asset Management reported no remaining American Renal Associates Holdings, Inc position as of Q3 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 12,387 American Renal Associates Holdings, Inc shares in Q3 2018, an estimated $195K.
  • Balyasny Asset Management first reported a position in American Renal Associates Holdings, Inc in Q2 2018 and held it in 1 quarter.
  • Balyasny Asset Management's American Renal Associates Holdings, Inc position peaked at $195K in Q2 2018.
  • 82 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.